Nonketotic hyperglycemic coma
Hyperosmolar diabetic coma (HNDC) is a rare, severe acute complication of diabetes, which is more common in elderly patients with no history of diabetes or mild non-insulin-dependent diabetes, but can also be seen in patients with insulin-dependent diabetes. The patient's original insulin secretion is insufficient, and the blood sugar rises rapidly under the influence of inducements, which promotes the aggravation of sugar metabolism disorders, causing the extracellular fluid to be hyperosmotic, hypovolemic hyperosmotic dehydration, and the original arteriosclerosis causing insufficient blood supply and hypoxia in the cerebral cortex, resulting in mental and neurological symptoms and coma.
-
Site of disease:
Brain Pancreas -
Infectious :
Not contagious -
Frequent population:
Elderly people, those with decreased renal function -
Related symptoms:
Polydipsia polyuria drowsiness thirst and polydipsia breath may smell like rotten apples -
Concurrent disease:
Related Drugs
repaglinide tablets
Indication: It is used for patients with type 2 diabetes (non-insulin-dependent) whose high blood sugar cannot be effectively controlled by diet control and exercise. Repaglinide tablets can be used together with metformin. Compared with the use of each alone, the combination of the two has a synergistic effect on controlling blood sugar.
Glimepiride Tablets
Indication: Used for type 2 diabetes mellitus in which diet, physical exercise and weight loss cannot satisfactorily control blood sugar.
Manufacturer:
Chongqing Kangke'er Pharmaceutical Co., Ltd.
Glimepiride Tablets
Indication: Used for type 2 diabetes mellitus in which diet, physical exercise and weight loss cannot satisfactorily control blood sugar.
Manufacturer:
Chongqing Kangke'er Pharmaceutical Co., Ltd.
Glimepiride Tablets
Indication: Used for type 2 diabetes mellitus in which diet, physical exercise and weight loss cannot satisfactorily control blood sugar.
Manufacturer:
Shandong Dyne Marine Organism Pharmaceutical Co., Ltd.
Glimepiride Tablets
Indication: Used for type 2 diabetes mellitus in which diet, physical exercise and weight loss cannot satisfactorily control blood sugar.
Glipizide Tablets
Indication: It is suitable for patients with mild to moderate type 2 diabetes who have not achieved satisfactory results after 2 to 3 months of diet control and physical exercise. The pancreatic islet b cells of such diabetic patients must have a certain insulin secretion function, and have no acute complications (such as infection, trauma, ketoacidosis, hyperosmolar coma, etc.), no pregnancy, and no serious chronic complications.
Glipizide Tablets
Indication: It is suitable for patients with mild to moderate type 2 diabetes who have not achieved satisfactory results after 2 to 3 months of diet control and physical exercise. The pancreatic islet b cells of such diabetic patients must have a certain insulin secretion function, and have no acute complications (such as infection, trauma, ketoacidosis, hyperosmolar coma, etc.), no pregnancy, and no serious chronic complications.
Manufacturer:
Tianjin Zhongtian Pharmaceutical Co., Ltd.
Glibenclamide Tablets
Indication: It is suitable for mild and moderate type 2 diabetes mellitus that is not effectively controlled by diet alone. The patient's pancreatic β cells have a certain insulin secretion function and there are no serious complications.
Manufacturer:
Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.
Glibenclamide Tablets
Indication: It is suitable for mild and moderate type 2 diabetes mellitus where diet alone has unsatisfactory effects. The patient's pancreatic b cells have a certain insulin secretion function and there are no serious complications.
Manufacturer:
Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd.
Gliclazide Tablets
Indication: Used for type 2 diabetes.